Peptinovo Biopharma

Peptinovo Biopharma Inc. is a small biotechnology company located in Ann Arbor, Michigan, with a team of four employees. The company was founded with a mission to improve cancer treatment by reducing the harmful side effects of chemotherapy. Peptinovo develops a targeted drug-delivery platform called Peptide-Amphiphile Lipid Micelle (PALM). This innovative technology aims to deliver higher doses of chemotherapy drugs directly into tumors while minimizing their impact on healthy tissues. Their initial focus is on eliminating the peripheral neuropathy caused by paclitaxel, a widely used chemotherapy drug for various cancers, including ovarian cancer. Peptinovo's PALM platform has the potential to improve the lives of cancer patients by reducing the debilitating side effects of chemotherapy, allowing them to complete their treatment regimen and experience better long-term outcomes. The company's technology is adaptable and can be applied to treat a wide range of cancers and used in conjunction with various chemotherapy drugs. For more information about Peptinovo Biopharma and their groundbreaking technology, please visit their website at peptinovo.com.